Peer-reviewed literature
Search biomedical papers by peptide name, mechanism, study design, or author. Read the abstract, full paper where available, and stated limitations.
Search PubMed01 Research Hub
Follow the claim back to the record.
The Field Guide helps readers orient themselves. This hub makes it easier to find the original paper, registered study, current label, or regulator record that can show what was studied, in whom, for how long, and with what limits.
02 Source finder
Three places to start.
The project does not yet publish a standalone verified study database. Until that record layer is built from primary sources, these public tools are the appropriate route to original material.
Registered studies
Check whether a study is registered, the population and outcomes it planned to examine, and whether the record is completed, ongoing, or withdrawn.
Search ClinicalTrials.govCurrent medicine information
For approved products, consult current official labelling and regulator databases rather than relying on a class-level or historical claim.
Search DailyMed03 Research PDF browser
Find a reading edition by context.
These are structured, source-led research PDFs. Tags describe the topic and evidence context covered by each edition; they are not endorsements, suitability labels, or medical advice.
10 editions shown
Research PDFMetabolic & incretin
Semaglutide
An evidence-led overview of GLP-1 receptor agonism, approved contexts, and evidence limits.
Research PDFMetabolic & incretin
Tirzepatide
A detailed guide to dual incretin research, current prescription context, and unanswered questions.
Research PDFEarly research
BPC-157
A research-stage evidence review that separates laboratory signals from established human knowledge.
Research PDFHormone signalling
CJC-1295
A cautious analysis of GHRH-analog research, regulatory status, and evidence limitations.
Research PDFHormone signalling
Ipamorelin
A plain-language review of growth-hormone secretagogue research and significant evidence gaps.
Research PDFMetabolic & incretin
Retatrutide
A source-led guide to investigational triple-receptor research, UK status, trial boundaries, and open questions.
Research PDFMetabolic & incretin
Cagrilintide
An evidence-first guide to amylin research, combination-study boundaries, UK development context, and uncertainty.
Research PDFHormone signalling
Tesamorelin
A careful reading guide to prescription context, HIV-lipodystrophy studies, safety limits, and original records.
Research PDFEarly research
TB-500
A source-led review of thymosin-beta-4 terminology, early research, sport rules, and substantial evidence gaps.
Research PDFCosmetic & laboratory context
GHK-Cu
A clear guide to copper-peptide biology, cosmetic context, model-specific findings, and claim boundaries.
04 Reading method
What should stay visible when you read a result?
- 01The question and setting
What did the researchers test, and which condition, population, or model was involved?
- 02The evidence type
Keep human, animal, laboratory, observational, and product-label information distinct.
- 03The comparison and outcome
Ask compared with what, for how long, and whether the reported outcome is clinically meaningful.
- 04The uncertainty
Read limitations, missing data, sample size, and whether another study has reached a similar result.
Free reference Better source reading
A seven-question guide for checking a claim.
Keep a concise, evidence-first PDF beside your next paper, trial record, or product claim. It explains the questions that preserve source, context, uncertainty, and ethical boundaries.
Important boundary Educational research navigation
Research information is not personal care.
Nothing in the Research Hub is a diagnosis, treatment plan, personal dosing guide, product recommendation, or substitute for a clinician who can consider individual circumstances. Experimental compounds may have significant unknowns, and published research can change over time.